Literature DB >> 5697047

Erythropoietic porphyrin hepatitis.

H D Barnes, E Hurworth, J H Millar.   

Abstract

The clinical history, laboratory, and necropsy findings in a patient with terminal jaundice and disordered porphyrin metabolism are presented. A retrospective diagnosis of erythropoietic protoporphyria is considered.

Entities:  

Mesh:

Year:  1968        PMID: 5697047      PMCID: PMC473714          DOI: 10.1136/jcp.21.2.157

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  7 in total

1.  [A NEW METABOLIC DISEASE OF ERYTHROCYTIC MANIFESTATION: ERYTHROPOIETIC PROTOPORPHYRIA].

Authors:  A GAJDOS; J CANET; A COMBRISSON; M GAJDOS-TOROK
Journal:  Nouv Rev Fr Hematol       Date:  1964 Jul-Aug

2.  CONGENITAL ERYTHROPOIETIC PROTOPORPHYRIA. I. CASE REPORTS, CLINICAL STUDIES AND PORPHYRIN ANALYSES IN TWO BROTHERS.

Authors:  F S PORTER; B A LOWE
Journal:  Blood       Date:  1963-11       Impact factor: 22.113

3.  ERYTHROPOIETIC PROTOPORPHYRIA.

Authors:  A G REDEKER; H G BRYAN
Journal:  Lancet       Date:  1964-06-27       Impact factor: 79.321

4.  ERYTHROPOIETIC PROTOPORPHYRIA AND PHOTOHEMOLYSIS.

Authors:  L C HARBER; A S FLEISCHER; R L BAER
Journal:  JAMA       Date:  1964-07-20       Impact factor: 56.272

5.  SEPARATION OF ETHER-EXTRACTABLE FECAL PORPHYRINS BY COUNTER-CURRENT DISTRIBUTION.

Authors:  J M FRENCH; M T ENGLAND; J LINES; E THONGER
Journal:  Arch Biochem Biophys       Date:  1964-09       Impact factor: 4.013

6.  BIOCHEMICAL AND FLUORESCENCE-MICROSCOPY SCREENING-TESTS FOR ERYTHROPOIETIC PROTOPORPHYRIA.

Authors:  C RIMINGTON; D J CRIPPS
Journal:  Lancet       Date:  1965-03-20       Impact factor: 79.321

7.  Erythropoietic protoporphyria in sisters.

Authors:  G HOLTI; I A MAGNUS; C RIMINGTON
Journal:  Br J Dermatol       Date:  1963-06       Impact factor: 9.302

  7 in total
  13 in total

Review 1.  The porphyrias: a review.

Authors:  G H Elder; C H Gray; D C Nicholson
Journal:  J Clin Pathol       Date:  1972-12       Impact factor: 3.411

2.  A light and electron microscopic study of the liver in case of erythrohepatic protoporphyria and in griseofulvin-induced porphyria in mice.

Authors:  A Matilla; E A Molland
Journal:  J Clin Pathol       Date:  1974-09       Impact factor: 3.411

3.  'Erythropoietic' protoporphyria and cirrhosis in sisters.

Authors:  R P Thompson; E A Molland; D C Nicholson; C H Gray
Journal:  Gut       Date:  1973-12       Impact factor: 23.059

4.  The liver and erythropoietic protoporphyria.

Authors: 
Journal:  Br Med J       Date:  1971-07-03

5.  Blood exchange and transfusion therapy for acute cholestasis in protoporphyria.

Authors:  H J van Wijk; J van Hattum; H Baart de la Faille; J W van den Berg; A Edixhoven-Bosdijk; J H Wilson
Journal:  Dig Dis Sci       Date:  1988-12       Impact factor: 3.199

6.  Phototoxicity of protoporphyrin as related to its subcellular localization in mice livers after short-term feeding with griseofulvin.

Authors:  S Sandberg; I Romslo
Journal:  Biochem J       Date:  1981-07-15       Impact factor: 3.857

7.  Exacerbation of erythropoietic protoporphyria by hyperthyroidism.

Authors:  Elisabeth I Minder; Andreas R Haldemann; Xiaoye Schneider-Yin
Journal:  J Inherit Metab Dis       Date:  2010-11-11       Impact factor: 4.982

8.  Protoporphyrin hepatopathy. Effects of cholic acid ingestion in murine griseofulvin-induced protoporphyria.

Authors:  M B Poh-Fitzpatrick; J A Sklar; C Goldsman; J H Lefkowitch
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

9.  An autopsy case of erythropoietic protoporphyria with cholestatic jaundice and hepatic failure, and a review of literature.

Authors:  Y Nakanuma; M Wada; N Kono; H Miyamura; G Ohta
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1981

10.  Heme synthetase deficiency in human protoporphyria. Demonstration of the defect in liver and cultured skin fibroblasts.

Authors:  H L Bonkowsky; J R Bloomer; P S Ebert; M J Mahoney
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.